Century Therapeutics Inc (IPSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 0 | 0 | 109,164 | 4,172 | 791 |
| Gross Profit | N/A | N/A | 109,164 | 4,172 | 791 |
| Operating Expenses | 36,124 | 34,664 | 34,988 | 41,456 | 35,580 |
| Operating Income | -36,124 | -34,664 | 74,176 | -37,284 | -34,789 |
| Other Income | 1,702 | 2,123 | 2,384 | 2,988 | 3,555 |
| Pre-tax Income | -34,422 | -32,541 | 76,560 | -34,296 | -31,234 |
| Income Tax | N/A | N/A | N/A | 1,775 | -8 |
| Net Income Continuous | -34,422 | -32,541 | 76,560 | -36,071 | -31,226 |
| Net Income | $-34,422 | $-32,541 | $76,560 | $-36,071 | $-31,226 |
| EPS Basic Total Ops | -0.40 | -0.38 | 0.89 | -0.41 | -0.37 |
| EPS Basic Continuous Ops | -0.40 | -0.38 | 0.89 | -0.41 | -0.37 |
| EPS Diluted Total Ops | -0.40 | -0.38 | 0.89 | -0.41 | -0.37 |
| EPS Diluted Continuous Ops | -0.40 | -0.38 | 0.89 | -0.41 | -0.37 |
| EPS Diluted Before Non-Recurring Items | -0.32 | -0.38 | 0.89 | -0.43 | -0.37 |
| EBITDA(a) | $-33,502 | $-32,110 | $76,543 | $-34,999 | $-32,812 |